<DOC>
	<DOCNO>NCT02840084</DOCNO>
	<brief_summary>Purpose : The purpose investigation test safety effectiveness Aspen System™ Aspen Rehabilitation Technique . The device intend therapeutic treatment capsular contracture breast conjunction Aspen Rehabilitation Technique . The hypothesis propose study external ultrasound Aspen System™ device conjunction Aspen Rehabilitation Technique safe effective reduction least one level Baker Grade III capsular contracture cosmetic breast augmentation patient , maintain one year final treatment . Potential benefit study subject include improvement grade capsular contracture breast without surgical treatment . The investigation plan last 12 month .</brief_summary>
	<brief_title>Aspen™ Ultrasound System Aspen Rehabilitation Technique Treatment Capsular Contracture</brief_title>
	<detailed_description>Protocol : Objectives : Two stage propose study . In Stage I , objective demonstrate safety Aspen System™ Aspen Rehabilitation Technique treatment Baker Grade III capsular contracture breast follow subglandular placement saline implant cosmetic breast augmentation . The endpoint determination safety define adverse event , include implant rupture . Following review interim data approval FDA , Stage II commence . In Stage II , objective demonstrate safety efficacy Aspen System™ Aspen Rehabilitation Technique treatment Baker Grade III capsular contracture breast follow subglandular submuscular placement saline silicone implant cosmetic breast augmentation . The endpoint documentation efficacy demonstrate reduction least one Baker Grade follow treatment Aspen™ System Aspen Rehabilitation Technique . Description : This prospective , non-randomized trial . Conduct : The trial conduct follow : Study Subjects : Patients recruit investigator 's private practice local community . In stage I , 10 woman age 22 year old receive saline breast implant subglandular breast augmentation , subsequently develop Baker Grade III capsular contracture , invited participate . Upon completion first stage study , data submit FDA review . The second stage study commence approval obtain FDA . At time , second stage study , study group expand include additional 50 patient receive saline silicone gel implant , place either subglandular submuscular position , Grade III capsular contracture breast .</detailed_description>
	<mesh_term>Contracture</mesh_term>
	<criteria>Stage I : Age 22 year great , Cosmetic breast augmentation , Baker Grade III capsular contracture , subglandular implant position , saline implant . Stage II : Age 22 year great , Cosmetic breast augmentation , Baker Grade III capsular contracture , subglandular submuscular implant position , saline silicone gel implant . History breast cancer , prior radiation therapy chest wall , rupture breast implant , calcification capsule see image study , implant &gt; 15 year old , prior treatment capsular contracture past 12 month ( open capsulectomy , open capsulotomy , implant exchange , implant plane change , placement acellular dermal matrix , explantation , close capsulotomy , oral medication ) , metal implant , pacemaker , defibrillator , history epilepsy , history bleeding , undiagnosed pain syndrome , pregnancy , currently lactate , acute subacute thrombosis thrombophlebitis , potentially malignant tumor , benign tumor , malignancy , thirddegree musculotendinous lesion , multiple sclerosis , osteomyelitis , cardiac arrhythmia , acute sepsis tissue bone , arteriosclerosis , hemophilia , sensory nerve damage .</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>breast implant capsular contracture</keyword>
</DOC>